Anti-Aging Peptide Therapies
After MSC Therapy: What to Measure at 1, 3 and 6 Months
A follow-up framework for recording benefit, nonresponse and adverse events without promising a universal stem-cell recovery timeline.
A follow-up framework for recording benefit, nonresponse and adverse events without promising a universal stem-cell recovery timeline.
by Ramon De La Puerta (Z-Lounge Regenerative Medicine and Stem Cell Therapy Centers) Stem cell therapy, especially using umbilical cord-derived mesenchymal stem cells (UC-MSCs), is an exciting frontier in regenerative medicine. But as with any medical treatment, patients naturally worry about safety: What are the side effects? Are there serious risks? In this article, we’ll explain precisely what UC-MSCs are, differentiate between mild
A patient guide to MSC signaling, immune effects and the difference between biological plausibility and demonstrated clinical benefit.